BE827659A - Medicament contenant comme constituant actif la sapogenine principale du genre helleport - Google Patents

Medicament contenant comme constituant actif la sapogenine principale du genre helleport

Info

Publication number
BE827659A
BE827659A BE6044981A BE6044981A BE827659A BE 827659 A BE827659 A BE 827659A BE 6044981 A BE6044981 A BE 6044981A BE 6044981 A BE6044981 A BE 6044981A BE 827659 A BE827659 A BE 827659A
Authority
BE
Belgium
Prior art keywords
helleport
genus
product containing
active constituent
medicinal product
Prior art date
Application number
BE6044981A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827659A publication Critical patent/BE827659A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y10S435/915—Aspergillus flavus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y10S435/916—Aspergillus fumigatus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y10S435/917—Aspergillus niger
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y10S435/918—Aspergillus oryzae

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE6044981A 1974-04-08 1975-04-07 Medicament contenant comme constituant actif la sapogenine principale du genre helleport BE827659A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2416978A DE2416978A1 (de) 1974-04-08 1974-04-08 Arzneimittel mit dem hauptsapogenin der helleborus-arten als wirkstoff

Publications (1)

Publication Number Publication Date
BE827659A true BE827659A (fr) 1975-10-07

Family

ID=5912425

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6044981A BE827659A (fr) 1974-04-08 1975-04-07 Medicament contenant comme constituant actif la sapogenine principale du genre helleport

Country Status (7)

Country Link
US (1) US3956491A (enExample)
AT (1) AT338968B (enExample)
BE (1) BE827659A (enExample)
DE (1) DE2416978A1 (enExample)
FR (1) FR2266509B1 (enExample)
GB (1) GB1502873A (enExample)
NL (1) NL7504106A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302611A (en) * 1980-10-07 1994-04-12 Klaus Keplinger Oxindole alkaloids having properties stimulating the immunologic system & preparation containing the same
MX164619B (es) * 1988-03-02 1992-09-09 Vicente Parrilla Cerrillo Composicion para el tratamiento de lesiones cutaneas
US5290557A (en) * 1992-07-16 1994-03-01 W. Neudorff Gmbh Kg Saponin containing anti-feedant and molluscicide for terrestrial mollusc control
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
TR200002773T2 (tr) * 1998-03-26 2001-11-21 Phytopharm Plc Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
RU2207141C2 (ru) * 2001-08-10 2003-06-27 Паршичев Герман Владимирович Биологически активный препарат - масло морозника
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366M (fr) * 1962-10-17 1964-03-02 Jouveinal Lab Médicament antiphlogistique a base de ruscogénine.

Also Published As

Publication number Publication date
GB1502873A (en) 1978-03-08
AT338968B (de) 1977-09-26
FR2266509B1 (enExample) 1980-01-04
US3956491A (en) 1976-05-11
ATA266775A (de) 1977-01-15
NL7504106A (nl) 1975-10-10
FR2266509A1 (enExample) 1975-10-31
DE2416978A1 (de) 1975-10-09

Similar Documents

Publication Publication Date Title
AU504474B2 (en) Inhalation of medicaments
BE845179A (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
SE411517B (sv) Inhalator for administration av pulverformiga substanser
BE827659A (fr) Medicament contenant comme constituant actif la sapogenine principale du genre helleport
AU497698B2 (en) Administering gas toa patient
FR2315268A1 (fr) Nouvelles lactones de prostaglandines, leur procede de preparation et medicament les contenant
FR2273554A1 (fr) Derives de prostaglandines et medicaments contenant ces substances
FR2289204A1 (fr) Nouveaux peptides et medicament contenant ces substances
FR2322593A1 (fr) Nouveaux analogues de prostaglandines et medicament les contenant
SE7809907L (sv) Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
ES434431A1 (es) Procedimiento para preparar derivados del xanteno.
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
BE824227A (fr) Nouveaux derives d'amidoxime, leur procede de prepatation ainsi que les compositions therapeutiques les contenant
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder
FR2278330A1 (fr) Nouvelles phenylisothiourees substituees, leur procede de preparation et medicament les contenant
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances
FR2279418A1 (fr) Polypeptides utilisables comme contraceptifs et medicament contenant ces substances
FR2281106A1 (fr) Nouveaux composes arythmiques et compositions pharmaceutiques contenant ces composes comme substances actives
FR2314724A1 (fr) Medicament anticonvulsif contenant un diphenylsilane
BE839309A (fr) Nouvel antibiotique, sa preparation et medicament le contenant
NO148883C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksyalkyl-diketoner og -keto-estere
FR2297845A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
BE824522A (fr) Nouveaux derives de l'indane utilisables notamment comme medicaments